|Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer|
G Liu, A Bollig-Fischer, B Kreike, MJ van de Vijver, J Abrams, SP Ethier, ...
Oncogene 28 (50), 4491-4500, 2009
|Overexpression of Cyclin D1 promotes tumor cell growth and confers resistance to Cisplatin-mediated apoptosis in an Elastase-myc transgene–expressing pancreatic tumor cell line|
H Biliran, Y Wang, S Banerjee, H Xu, H Heng, A Thakur, A Bollig, ...
Clinical Cancer Research 11 (16), 6075-6086, 2005
|An estrogen receptor-α splicing variant mediates both positive and negative effects on gene transcription|
A Bollig, RJ Miksicek
Molecular endocrinology 14 (5), 634-649, 2000
|Genes associated with prostate cancer are differentially expressed in African American and European American men|
IJ Powell, G Dyson, S Land, J Ruterbusch, CH Bock, S Lenk, M Herawi, ...
Cancer Epidemiology and Prevention Biomarkers 22 (5), 891-897, 2013
|Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells|
A Thakur, Y Sun, A Bollig, J Wu, H Biliran, S Banerjee, FH Sarkar, DJ Liao
Clinical cancer research 14 (14), 4427-4436, 2008
|Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer|
A Thakur, KMW Rahman, J Wu, A Bollig, H Biliran, X Lin, H Nassar, ...
Molecular Cancer Research 5 (2), 171-181, 2007
|Expression profile of microRNAs in c-Myc induced mouse mammary tumors|
Y Sun, J Wu, S Wu, A Thakur, A Bollig, Y Huang, DJ Liao
Breast cancer research and treatment 118 (1), 185-196, 2009
|Transforming properties of 8p11-12 amplified genes in human breast cancer|
ZQ Yang, G Liu, A Bollig-Fischer, CN Giroux, SP Ethier
Cancer research 70 (21), 8487-8497, 2010
|Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes|
ST Guest, ZR Kratche, A Bollig-Fischer, R Haddad, SP Ethier
Experimental cell research 332 (2), 223-235, 2015
|Minireview: the molecular and genomic basis for prostate cancer health disparities|
IJ Powell, A Bollig-Fischer
Molecular endocrinology 27 (6), 879-891, 2013
|Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4|
A Ahmad, KR Ginnebaugh, S Yin, A Bollig-Fischer, KB Reddy, FH Sarkar
BMC cancer 15 (1), 1-10, 2015
|Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1|
B Bao, AS Azmi, A Aboukameel, A Ahmad, A Bolling-Fischer, S Sethi, ...
Journal of Biological Chemistry 289 (21), 14520-14533, 2014
|Intronic non-CG DNA hydroxymethylation and alternative mRNA splicing in honey bees|
P Cingolani, X Cao, RS Khetani, CC Chen, M Coon, A Bollig-Fischer, ...
BMC genomics 14 (1), 1-15, 2013
|C-Myc–induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-κB activity in pancreatic cancer cells|
H Biliran, S Banerjee, A Thakur, FH Sarkar, A Bollig, F Ahmed, J Wu, ...
Clinical cancer research 13 (9), 2811-2821, 2007
|Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice|
Y Wang, A Thakur, Y Sun, J Wu, H Biliran, A Bollig, DJ Liao
Cancer research 67 (8), 3698-3707, 2007
|Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity|
B Bao, C Mitrea, P Wijesinghe, L Marchetti, E Girsch, RL Farr, JL Boerner, ...
Scientific reports 7 (1), 1-11, 2017
|Methylation‐associated silencing of SFRP1 with an 8p11‐12 amplification inhibits canonical and non‐canonical WNT pathways in breast cancers|
ZQ Yang, G Liu, A Bollig‐Fischer, R Haddad, AL Tarca, SP Ethier
International journal of cancer 125 (7), 1613-1621, 2009
|Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice|
A Thakur, A Bollig, J Wu, DJ Liao
Molecular cancer 7 (1), 1-16, 2008
|The role of X-linked genes in breast cancer|
A Thakur, H Xu, Y Wang, A Bollig, H Biliran, JD Liao
Breast cancer research and treatment 93 (2), 135-143, 2005
|Racial diversity of actionable mutations in non–small cell lung cancer|
A Bollig-Fischer, W Chen, SM Gadgeel, AS Wenzlaff, ML Cote, ...
Journal of Thoracic Oncology 10 (2), 250-255, 2015